By Marc Dresner, IIR
Much like an ocean liner, the pharmaceutical industry has difficulty accommodating rapid shifts in direction, but advancements in healthcare technology, among other factors, are driving some pretty significant changes that will inevitably force the industry—clinical research and development, in particular—to adapt with relative urgency.
Still, progress needn't be a question of the chicken or the egg.
That’s according to Deirdre BeVard, VP, Development Operations at Endo Pharmaceuticals, who's cultivated a reputation for driving innovation from within the organization.
“We are still doing things in clinical development in very similar ways to how they’ve been done for the past 20 years. Something has to give,” BeVard told Inside Clinical.
“We’re hearing and speaking a lot about disruptive innovation, and that’s not going to come from the existing model or system,” she added. “[Clinical development and research are] going to look very different. There are going to be new players that may not be obvious to us now.”
BeVard pointed to crowdsourcing of trials, virtual trials, wireless technologies that passively collect clinical data directly from patients, etc. “There could be a day when we don’t have investigative sites,” she noted.
In this exclusive interview for the Inside Clinical podcast series, BeVard discusses:
- • How the drug development and clinical research environment is transforming
- • What those changes mean from an organizational perspective
- • The implications for conventional skill sets
- • The rise of broad-based collaboration and partnering, and much more…
Listen to the podcast.
Download the transcript.
Editor’s note: If you would like to meet and hear more from Deirdre BeVard, she’ll be Co-Chairing the 22nd Annual Partnerships in Clinical Trials Conference running April 21st through the 24th in Orlando.
For more information, please visit www.clinicaltrialpartnerships.com and download our brochure.
Register today and mention code XP1806BLOG to save 15% off the standard rate!
ABOUT THE AUTHOR/INTERVIEWER
Marc Dresner is IIR USA's senior editor and special communication projects lead. He is the former executive editor of Pharma Market Research Report, a confidential newsletter for market researchers in the pharmaceutical industry. He may be reached at firstname.lastname@example.org. Follow him @mdrezz.